PE(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

WIFLVHIKWGINAQ-OAVPECNCSA-N

InChI Key

WIFLVHIKWGINAQ-OAVPECNCSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

Preferred name

PE(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:184148

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_Plasma_vs_WY-14,643_Plasma
• Control_vs_AONFH_Stage_III_IV
• WT_vs_WT_Aco
• Control_vs_Exercise
• Control_12h_vs_Toxocara canis_12h
• BSA_Control_vs_AA